| MSM with identified PrEP-needa,b | OR (95% CI) | p valuec | aORd (95% CI) | p valuec | |
---|---|---|---|---|---|---|
Current PrEP use | No current PrEP use | |||||
n = 201 | n = 431 | |||||
Service engagement and outcomes | ||||||
 ≥ 4 HIV tests in the last year | ||||||
 No | 41.5% (83/200) | 86.9% (351/404) | 1.00 (ref) |  < 0.001 | 1.00 (ref) |  < 0.001 |
 Yes | 58.5% (117/200) | 13.1% (53/404) | 9.34 (6.24–14.0) |  | 9.68 (6.35–14.8) |  |
Location of last HIV test | ||||||
 Other | 8.0% (16/200) | 30.3% (125/413) | 1.00 (ref) |  < 0.001 | 1.00 (ref) |  < 0.001 |
 SHC | 92.0% (184/200) | 69.7% (288/413) | 4.99 (2.87–8.67) |  | 5.28 (2.97–9.36) |  |
STI diagnosis in the last year | ||||||
 No | 35.8% (72/201) | 80.8% (344/426) | 1.00 (ref) |  < 0.001 | 1.00 (ref) |  < 0.001 |
 Yes | 64.2% (129/201) | 19.3% (82/426) | 7.52 (5.16–10.9) |  | 8.46 (5.69–12.6) |  |
Sexual risk and prevention behaviours | ||||||
 ≥ 5 CAS partners in the last year | ||||||
 No | 33.3% (66/198) | 81.8% (342/418) | 1.00 (ref) |  < 0.001 | 1.00 (ref) |  < 0.001 |
 Yes | 66.7% (132/198) | 18.2% (76/418) | 9.00 (6.11–13.2) |  | 10.1 (6.71–15.2) |  |
 ≥ 2 casual CAS partners in the last year | ||||||
 No | 24.6% (46/187) | 73.0% (267/366) | 1.00 (ref) |  < 0.001 | 1.00 (ref) |  < 0.001 |
 Yes | 75.4% (141/187) | 27.1% (99/366) | 8.27 (5.51–12.4) |  | 9.21 (6.03–14.1) |  |
Chemsex in the last yeare | ||||||
 No | 62.9% (122/194) | 82.1% (339/413) | 1.00 (ref) |  < 0.001 | 1.00 (ref) |  < 0.001 |
 Yes | 37.1% (72/194) | 17.9% (74/413) | 2.70 (1.84–4.00) |  | 2.85 (1.90–4.27) |  |
Purchase of antibiotics to prevent STIsf | ||||||
 No | 86.3% (170/197) | 96.4% (397/412) | 1.00 (ref) |  < 0.001 | 1.00 (ref) |  < 0.001 |
 Yes | 13.7% (27/197) | 3.6% (15/412) | 4.20 (2.18–8.10) |  | 4.58 (2.33–9.02) |  |
Ever used PEP | ||||||
 No | 55.8% (111/199) | 86.5% (370/428) | 1.00 (ref) |  < 0.001 | 1.00 (ref) |  < 0.001 |
 Yes | 44.2% (88/199) | 13.6% (58/428) | 5.06 (3.41–7.50) |  | 4.95 (3.30–7.41) |  |